ConductScience.org, home

Paper42409264

Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases.

Walker SM and 29 others. J Biol Chem, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases. Papers, record 42409264. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42409264

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases.
PubMed
Journal
J Biol Chem
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-27
PubMed

Authors30

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Walker SMSimon M
2Loutan AJArlo J
3Tchesnokov EPEgor P
4Kocincova DDana
5Gordon CJCalvin J
6Escobedo RARuby A
7Jackson NNathaniel
8Vogel OAOlivia A
9Morsheimer KKim
10Park SSuncheol
11Gharpure AAnant
12Urbano IIxchel
13Heacock MMina
14Chen ZZhong
15Pathak KKhushboo
16Wolff KCKaren C
17Huerta LLauren
18Bakowski MAMalina A
19Riva LLaura
20Gupta AKAnil K

Source PubMed

See all 30 authorsDownload CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
RNA-Dependent RNA PolymeraseMajor topic
Enzyme InhibitorsMajor topic
Substrate Specificity
Humans
Adenosine

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
U19 AI171443NIAID NIH HHSUnited StatesU19AI171443PubMed

Source NIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of42244653Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases.https://conductscience.org/library/papers/42244653

Source PubMed

Download CSV of comments and corrections

References92

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131412589A Comprehensive Superposition of Viral Polymerase Structures.Viruses2019https://conductscience.org/library/papers/31412589PubMed
227645237Antiviral Nucleotide Incorporation by Recombinant Human Mitochondrial RNA Polymerase Is Predictive of Increased In Vivo Mitochondrial Toxicity Risk.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27645237PubMed
310381167Intracellular activation of 2',3'-dideoxyinosine and drug interactions in vitro.AIDS Res Hum Retroviruses1999https://conductscience.org/library/papers/10381167PubMed
434653416Remdesivir overcomes the S861 roadblock in SARS-CoV-2 polymerase elongation complex.Cell Rep2021https://conductscience.org/library/papers/34653416PubMed
526284260High-Throughput Minigenome System for Identifying Small-Molecule Inhibitors of Ebola Virus Replication.ACS Infect Dis2015https://conductscience.org/library/papers/26284260PubMed
610972629Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity.Clin Ther2000https://conductscience.org/library/papers/10972629PubMed
729067766MolProbity: More and better reference data for improved all-atom structure validation.Protein Sci2018https://conductscience.org/library/papers/29067766PubMed
838096902Structures, functions and adaptations of the human LINE-1 ORF2 protein.Nature2024https://conductscience.org/library/papers/38096902PubMed
939638153Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4'-fluorouridine.Antiviral Res2025https://conductscience.org/library/papers/39638153PubMed
10370680764'-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza viruses.PLoS Pathog2023https://conductscience.org/library/papers/37068076PubMed
1115568020Baculovirus expression system for heterologous multiprotein complexes.Nat Biotechnol2004https://conductscience.org/library/papers/15568020PubMed
1237623252Recent Advances in Molecular Mechanisms of Nucleoside Antivirals.Curr Issues Mol Biol2023https://conductscience.org/library/papers/37623252PubMed
1315217303Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics.Clin Pharmacokinet2004https://conductscience.org/library/papers/15217303PubMed
1429891600Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29891600PubMed
1533961695β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells.J Infect Dis2021https://conductscience.org/library/papers/33961695PubMed
1619843980Anti-hepatitis C virus activity of novel beta-d-2'-C-methyl-4'-azido pyrimidine nucleoside phosphoramidate prodrugs.Antivir Chem Chemother2009https://conductscience.org/library/papers/19843980PubMed
1711526116Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase.J Biol Chem2001https://conductscience.org/library/papers/11526116PubMed
1836567022Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2.Antiviral Res2023https://conductscience.org/library/papers/36567022PubMed
1936725929Structural basis for substrate selection by the SARS-CoV-2 replicase.Nature2023https://conductscience.org/library/papers/36725929PubMed
2029507309Recombinant RNA-Dependent RNA Polymerase Complex of Ebola Virus.Sci Rep2018https://conductscience.org/library/papers/29507309PubMed

See all 92 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42409264

GET https://conductscience.org/api/papers/v1/42409264/authors?page=2